Related Experiment Videos
Specific labelling of brain receptors with [3H]N-acetyl-aspartyl-glutamate
European Journal of Pharmacology
|September 3, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
My Life in Clinical Neuroscience: The Beginning.
Advances in pharmacology (San Diego, Calif.)·2016
The neuroscience perspective and the changing role of the psychiatrist : the challenge for psychiatric educators.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.
Genes, brain, and behavior·2010
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.
The American journal of bioethics : AJOB·2009
Taurocholic acid attenuates hepatic inflammation in MASH and modulates the PPARγ/NF-κB axis.
European journal of pharmacology·2026
Polydatin Encapsulated in Human Serum Albumin Nanoparticles Attenuates Oxidative Damage and Protects Rotenone-Induced Neuroblastoma cells.
European journal of pharmacology·2026
Sodium butyrate combined with ethanol-metabolizing Lactobacillus strains attenuates alcoholic liver disease by restoring gut-liver homeostasis.
European journal of pharmacology·2026
Rhein Attenuates Neointimal Hyperplasia by Inhibiting VSMC Proliferation via MAPK-Mediated Downregulation of CDC45.
European journal of pharmacology·2026
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026